| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Armes Joseph B | Chairman, President & CEO, Director | 5420 LYNDON B JOHNSON FWY, STE. 500, DALLAS | /s/Luke E. Alverson, Attorney in Fact | 09 May 2025 | 0001413614 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CSWI | Common Stock | 66,522 | 07 May 2025 | Direct | ||||||
| holding | CSWI | Common Stock | 3,143 | 07 May 2025 | by ESOP |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSWI | Performance Rights | Award | $0 | +8,004 | $0.000000 | 8,004 | 07 May 2025 | Common Stock | 8,004 | Direct | F1 | ||
| holding | CSWI | Performance Rights | 8,236 | 07 May 2025 | Common Stock | 8,236 | Direct | F2 | ||||||
| holding | CSWI | Performance Rights | 12,422 | 07 May 2025 | Common Stock | 12,422 | Direct | F3 | ||||||
| holding | CSWI | Performance Rights | 18,372 | 07 May 2025 | Common Stock | 18,372 | Direct | F4 | ||||||
| holding | CSWI | Restricted Stock Units | 19,685 | 07 May 2025 | Common Stock | 19,685 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025 and ending on March 31, 2028 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F2 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F3 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F4 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles beginning April 1, 2021 ending on each of March 31, 2026 and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F5 | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vests upon the successful first employment anniversary of a successor Chief Executive Officer. |